Inventor · disambiguated record
Ira D. Goldfine
Also filed as: GOLDFINE IRA · GOLDFINE IRA D
14 granted patents·7 pending applications·558 citations·filing 1994–2016
94Inventor score
Top patents by PatentIndex Score
21 records- 0192US6225290B1Systemic gene therapy by intestinal cell transformationUNIV CALIFORNIA·Filed 1996·Granted May 1, 2001·86 cites·14 claims
- 0285US6004944AProtein delivery by secretory gland expressionUNIV CALIFORNIA·Filed 1997·Granted Dec 21, 1999·46 cites·31 claims
- 0384US6465185B1Polymorphic human PC-1 sequences associated with insulin resistanceINST DI RICOVERO E CURA A CARA·Filed 1999·Granted Oct 15, 2002·213 cites·3 claims
- 0483US6258789B1Delivery of gene products by intestinal cell expressionUNIV CALIFORNIA·Filed 1997·Granted Jul 10, 2001·50 cites·5 claims
- 0580US10253101B2Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemiaXOMA US LLC·Filed 2016·Granted Apr 9, 2019·2 cites·33 claims
- 0680US5885971AGene therapy by secretory gland expressionUNIV CALIFORNIA·Filed 1996·Granted Mar 23, 1999·40 cites·11 claims
- 0778US6831070B2Delivery of therapeutic gene products by intestinal cell expressionUNIV CALIFORNIA·Filed 2001·Granted Dec 14, 2004·6 cites·38 claims
- 0877US5837693AIntravenous hormone polypeptide delivery by salivary gland expressionUNIV CALIFORNIA·Filed 1995·Granted Nov 17, 1998·50 cites·5 claims
- 0974US6531455B1Delivery of polynucleotides by secretory gland expressionUNIV CALIFORNIA·Filed 2000·Granted Mar 11, 2003·3 cites·2 claims
- 1072US6566342B2Gene therapy by secretory gland expressionUNIV CALIFORNIA·Filed 2001·Granted May 20, 2003·2 cites·5 claims
- 1171US8143226B2Tyrosine kinase receptor antagonists and methods of treatment for breast cancerGOLDFINE IRA·Filed 2006·Granted Mar 27, 2012·2 cites·12 claims
- 1265US6255289B1Gene delivery by secretory gland expressionUNIV CALIFORNIA·Filed 1998·Granted Jul 3, 2001·18 cites·8 claims
- 1365US2005026863A1Delivery of therapeutic gene products by intestinal cell expressionUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 1463US5968508AAntagonists to insulin receptor tyrosine kinase inhibitorUNIV CALIFORNIA·Filed 1995·Granted Oct 19, 1999·29 cites·5 claims
- 1563US2004127448A1Delivery of polypeptides by secretory gland expressionUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 1658US2003078226A1Delivery of polypeptides by secretory gland expressionFiled 2002·Application pending·0 cites
- 1758US2008085874A1Small molecule potentiator of hormonal therapy for breast cancerUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 1858US2002193337A1Gene therapy by secretory gland expressionFiled 2002·Application pending·0 cites
- 1944US2012214758A1Tyrosine kinase receptor antagonists and methods of treatment for pancreatic cancerGOLDFINE IRA·Filed 2012·Application pending·0 cites
- 2043US5939269AAntagonists to insulin receptor tyrosine kinase inhibitorUNIV CALIFORNIA·Filed 1994·Granted Aug 17, 1999·11 cites·12 claims
- 2142US2009280112A1Inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cellsUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ira D. Goldfine files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →